AZNVD
AstraZeneca PLC
Healthcare · Drug Manufacturers - General · GB
Jun 23, 2026, 05:30 UTC
Korea Health Industry Development Institute held partnering sessions for 13 Korean biotech companies with AstraZeneca under Project NOVA at the BIO International Convention in San Diego.
Source:Jun 12, 2026, 22:44 UTC
The US FDA approved AstraZeneca's TRUQAP (capivasertib) combination as a targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer.
Source:Jun 9, 2026, 13:35 UTC
AstraZeneca reported encouraging mid-stage trial results for its experimental weight-loss pill elecoglipron, showing 11.8% weight loss after 36 weeks.
Jun 5, 2026, 00:00 UTC
AbCellera Biologics Inc. appointed Victor Sandor as a Director, effective June 1, 2026.
← PreviousPage 3